Skip to main content
. 2006 Oct 21;12(39):6366–6370. doi: 10.3748/wjg.v12.i39.6366

Table 2.

Cure rates and drug-related adverse events reported by treatment groups

MBZ group QC group
n = 61 n = 61
Cure rate 48 (78.7%) 51 (83.6%)
Any adverse event 14 (22.9%) 36 (59%)
Abdominal pain 11 (18 %) 10 (16.3%)
Vomiting 3 (4.9%) 14 (22.9%)
Nausea 3 (4.9%) 14 (22.9%)
Headache 1 (1.6%) 11 (18%)
Yellowish coloration of the skin - 15 (24.6%)